[go: up one dir, main page]

AU2001266392A1 - The controlled release preparation of insulin and its method - Google Patents

The controlled release preparation of insulin and its method

Info

Publication number
AU2001266392A1
AU2001266392A1 AU2001266392A AU6639201A AU2001266392A1 AU 2001266392 A1 AU2001266392 A1 AU 2001266392A1 AU 2001266392 A AU2001266392 A AU 2001266392A AU 6639201 A AU6639201 A AU 6639201A AU 2001266392 A1 AU2001266392 A1 AU 2001266392A1
Authority
AU
Australia
Prior art keywords
insulin
controlled release
release preparation
preparation
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266392A
Inventor
Sung-Hee Choi
Chan-Hwa Kim
Jai-Hyun Kwon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MI Tech Co Ltd
Original Assignee
MI Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020000085698A external-priority patent/KR100342746B1/en
Application filed by MI Tech Co Ltd filed Critical MI Tech Co Ltd
Publication of AU2001266392A1 publication Critical patent/AU2001266392A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2001266392A 2000-06-27 2001-06-25 The controlled release preparation of insulin and its method Abandoned AU2001266392A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR2000/35760 2000-06-27
KR20000035760 2000-06-27
KR2000/85698 2000-12-29
KR1020000085698A KR100342746B1 (en) 2000-06-27 2000-12-29 Controlled release preparation of insulin and its method
PCT/KR2001/001085 WO2002000207A1 (en) 2000-06-27 2001-06-25 The controlled release preparation of insulin and its method

Publications (1)

Publication Number Publication Date
AU2001266392A1 true AU2001266392A1 (en) 2002-01-08

Family

ID=26638148

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266392A Abandoned AU2001266392A1 (en) 2000-06-27 2001-06-25 The controlled release preparation of insulin and its method

Country Status (6)

Country Link
US (1) US7087246B2 (en)
EP (1) EP1296660A4 (en)
JP (1) JP2004501188A (en)
CN (1) CN100345535C (en)
AU (1) AU2001266392A1 (en)
WO (1) WO2002000207A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2537721A1 (en) 2003-09-05 2005-03-24 University Of Massachusetts Amphiphilic polymer capsules and related methods of interfacial assembly
EP2626368B1 (en) * 2004-07-19 2016-12-21 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
BRPI0608844A2 (en) * 2005-03-09 2010-02-02 Ono Pharmaceutical Co particle and preparation containing the particle
CA2634974A1 (en) 2005-12-30 2007-07-12 Zensun (Shanghai) Science & Technology, Ltd. Extended release of neuregulin for improved cardiac function
KR100853309B1 (en) * 2006-11-01 2008-08-20 나재운 Sustained-release and biodegradable nanoparticles of polylactide glycolide copolymer loaded with ciprofloxacin and preparation method thereof
JP5302952B2 (en) * 2007-04-19 2013-10-02 ドン・ア・ファーム・カンパニー・リミテッド Biodegradable microsphere composition suitable for controlled release of glycoregulatory peptide and method for producing the same
US8685458B2 (en) 2009-03-05 2014-04-01 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives
JP5491119B2 (en) * 2009-10-02 2014-05-14 日東電工株式会社 Pharmaceutical composition containing drug-containing microparticles and method for producing the same
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
CN102144976A (en) * 2011-01-19 2011-08-10 谢坤 Method for preparing insulin dry powder for oral administration by using micro capsulation technology
US9084727B2 (en) 2011-05-10 2015-07-21 Bend Research, Inc. Methods and compositions for maintaining active agents in intra-articular spaces
BRPI1103164A2 (en) * 2011-06-13 2013-07-23 Univ Rio De Janeiro insulin confinement polymeric system, process and use of said system
RU2014120626A (en) * 2014-05-22 2015-11-27 Владимир Андреевич Сабецкий INSULIN-CONTAINING MEDICINE OF LONG-TERM ACTION
DK3166595T3 (en) 2014-07-08 2019-08-05 Amphastar Pharmaceuticals Inc MICRONIZED INSULIN, MICRONIZED INSULIN ANALOGS, AND METHODS OF PRODUCING THEREOF
US10322168B2 (en) 2016-01-07 2019-06-18 Amphastar Pharmaceuticals, Inc. High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
GB201622024D0 (en) * 2016-11-14 2017-02-08 Inventage Lab Inc Apparatus and method for large scale production of monodisperse, microsheric and biodegradable polymer-based drug delivery
WO2019169370A1 (en) * 2018-03-02 2019-09-06 University Of The Sciences Polymer compositions for storage and release of polypeptides
CN108553639B (en) * 2018-04-25 2022-04-19 福州大学 A kind of chitosan/insulin nano sustained-release transdermal preparation and preparation method thereof
BR112022006750A2 (en) * 2019-10-08 2022-06-28 Incube Labs Llc DELIVERY DEVICE, DELIVERY DEVICE FOR CONTROLLING A DELIVERY PROFILE OF A THERAPEUTIC SUBSTANCE, AND METHOD FOR FORMING A DELIVERY DEVICE
CN120857928A (en) * 2023-03-17 2025-10-28 浙江大学 A controlled-release preparation and its preparation method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE35862E (en) * 1986-08-18 1998-07-28 Emisphere Technologies, Inc. Delivery systems for pharmacological agents encapsulated with proteinoids
GB9116610D0 (en) * 1991-08-01 1991-09-18 Danbiosyst Uk Preparation of microparticles
CN1098026A (en) * 1993-07-30 1995-02-01 吴道澄 Process for preparing nm-class capsules of cyanoacrylate by semi-continuous emulsion polymerizing process
JP4117922B2 (en) * 1996-03-28 2008-07-16 武田薬品工業株式会社 Sustained release preparation and production method thereof
CN1075945C (en) * 1998-02-26 2001-12-12 中国科学院化学研究所 High-polymer encapsulated insulin microsome and its preparation method and use
EP2311436A1 (en) 1998-04-27 2011-04-20 Altus Pharmaceuticals Inc. Stabilized protein crystals, formulations containing them and methods of making them
CN1253018A (en) * 1998-11-03 2000-05-17 中国医学科学院生物医学工程研究所 Nm-class insulin particles and their preparing process
KR100327597B1 (en) * 1999-04-27 2002-03-07 김찬화 A Process for insulin microcrystalization
DK2280020T3 (en) * 1999-06-29 2016-05-02 Mannkind Corp Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine

Also Published As

Publication number Publication date
CN100345535C (en) 2007-10-31
EP1296660A4 (en) 2005-04-13
US7087246B2 (en) 2006-08-08
US20030125237A1 (en) 2003-07-03
WO2002000207A1 (en) 2002-01-03
EP1296660A1 (en) 2003-04-02
WO2002000207A9 (en) 2005-07-21
CN1438881A (en) 2003-08-27
JP2004501188A (en) 2004-01-15

Similar Documents

Publication Publication Date Title
AU2001286677A1 (en) Controlled release of substances
AU2001266392A1 (en) The controlled release preparation of insulin and its method
AU2001290825A1 (en) Controlled release formulations and methods for their production and use
AU2002227414A1 (en) Infusion devices and method
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001253411A1 (en) Medical dressing assembly and associated method of using the same
AU2001234473A1 (en) Stabilized silica and methods of making and using the same
IL186782A0 (en) Controlled release composition and method of producing the same
AU2002224079A1 (en) O/W emulsion composition and method of preparing the same
AU2001245288A1 (en) Overhanging form system and method of using the same
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2000266079A1 (en) Chitosan and method of preparing chitosan
AU2001256373A1 (en) Syringe and method for the use thereof
AU2002215014A1 (en) Method and device for the preparation of fuels
AU2001260774A1 (en) Bio-support and preparing method of the same
AU4213299A (en) Controlled release of substances
AU5116100A (en) Connector and method of use of the connector
AU2001232948A1 (en) Controlled release of drugs
AU2002224035A1 (en) Composite element and method for preparation thereof
AU2002228801A1 (en) Post-crepe stabilized material and method of producing the same
AU2001295672A1 (en) Vaccine composition and stabilisation method
AU2002230413A1 (en) Pigment dispersion and method of preparing the same
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2003215947A1 (en) Controlled release composition comprising felodipine and method of preparation thereof